Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (511-520 of 626) with videos related to

Pageof 63
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|April 10, 2019
Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11β-hydroxylase and aldosterone synthaseMuhammad Akram, Melanie Patt, Teresa Kaserer, et al.
Journal of Medicinal Chemistry|November 14, 2012
Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosisSandrine Marchais-Oberwinkler, Kuiying Xu, Marie Wetzel, et al.
Journal of Medicinal Chemistry|August 5, 2008
Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivityRalf Heim, Simon Lucas, Cornelia M Grombein, et al.
Leukemia Research|January 1, 1986
Human leukemic cells: receptor binding and biological effects of insulin and insulin-like growth factorsU Vetter, J H Schlickenrieder, J Zapf, et al.
Neuro-Ophthalmology (Aeolus Press)|July 18, 2019
Papilloedema from Dural Venous Sinus Compression by MeningiomasAlexander J P W Hartmann, Michelle W Latting, Michael S Lee, et al.
Health Services Research|July 22, 2009
Comparing safety climate between two populations of hospitals in the United StatesSara J Singer, Christine W Hartmann, Amresh Hanchate, et al.
Journal of Medicinal Chemistry|August 8, 2013
Discovery and biophysical characterization of 2-amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulenceMichael Zender, Tobias Klein, Claudia Henn, et al.
Disease Management : DM|March 24, 2004
Impact of appropriate pharmaceutical therapy for chronic conditions on direct medical costs and workplace productivity: a review of the literatureNeil Goldfarb, Christine Weston, Christine W Hartmann, et al.
Journal of Medicinal Chemistry|May 30, 2003
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapyOmoshile O Clement, Clive M Freeman, Rolf W Hartmann, et al.
Chemmedchem|January 28, 2021
Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH)Katrin Voos, Esther Schönauer, Alaa Alhayek, et al.
Pageof 63

Showing results (511-520 of 626) with videos related to

Sort By:
Pageof 63
The Journal of Steroid Biochemistry and Molecular Biology|April 10, 2019
Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11β-hydroxylase and aldosterone synthaseMuhammad Akram, Melanie Patt, Teresa Kaserer, et al.
Journal of Medicinal Chemistry|November 14, 2012
Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosisSandrine Marchais-Oberwinkler, Kuiying Xu, Marie Wetzel, et al.
Journal of Medicinal Chemistry|August 5, 2008
Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivityRalf Heim, Simon Lucas, Cornelia M Grombein, et al.
Leukemia Research|January 1, 1986
Human leukemic cells: receptor binding and biological effects of insulin and insulin-like growth factorsU Vetter, J H Schlickenrieder, J Zapf, et al.
Neuro-Ophthalmology (Aeolus Press)|July 18, 2019
Papilloedema from Dural Venous Sinus Compression by MeningiomasAlexander J P W Hartmann, Michelle W Latting, Michael S Lee, et al.
Health Services Research|July 22, 2009
Comparing safety climate between two populations of hospitals in the United StatesSara J Singer, Christine W Hartmann, Amresh Hanchate, et al.
Journal of Medicinal Chemistry|August 8, 2013
Discovery and biophysical characterization of 2-amino-oxadiazoles as novel antagonists of PqsR, an important regulator of Pseudomonas aeruginosa virulenceMichael Zender, Tobias Klein, Claudia Henn, et al.
Disease Management : DM|March 24, 2004
Impact of appropriate pharmaceutical therapy for chronic conditions on direct medical costs and workplace productivity: a review of the literatureNeil Goldfarb, Christine Weston, Christine W Hartmann, et al.
Journal of Medicinal Chemistry|May 30, 2003
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapyOmoshile O Clement, Clive M Freeman, Rolf W Hartmann, et al.
Chemmedchem|January 28, 2021
Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH)Katrin Voos, Esther Schönauer, Alaa Alhayek, et al.
Pageof 63